MUMBAI, India, June 19 -- Intellectual Property India has published a patent application (202647066436 A) filed by Biocryst Pharmaceuticals, Inc. on May 27, 2026, for Anti-C2 Binding Agents And Conjugates Thereof.
Inventors include Babu, Yarlagadda, S.; Chen, Xilin; Wu, Mousheng; Ma, Yuanyuan, X.; and Cheng, Xiaogang.
The application for the patent was published on June 05, 2026, under issue no. 23/2026.
Abstract: The present disclosure relates to, inter ala, compounds (e.g., antibodies or antigen binding fragments thereof, or conjugates thereof) that bind to complement protein 2 (C2), and the use of the compounds in methods for treating, or ameliorating one or more symptoms of a disease or disorder associated with the complement pathway.
Disclaimer: Curated by HT Syndication.
